Medical Sciences · Nov 16, 2026

Conventional and Emerging Hematological Inflammatory Indices in Metabolic Syndrome: Narrative Review of Clinical Significance and Response to Bariatric Surgery

By Silva CHM, Mendes DFH, Mendes JOH et al.

Background: Metabolic syndrome (MetS) is associated with chronic low-grade systemic inflammation. Complete blood count-derived inflammatory indices and biochemical ratios have emerged as accessible, low-cost markers of inflammation and potential indicators of cardiometabolic risk. Objective: This narrative review examined the clinical relevance of hematological inflammatory indices in MetS, focusing on the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), and pan-immune-inflammation value (PIV), as well as the uric acid-to-HDL cholesterol ratio (UHR) and changes following bariatric surgery (BS). Methods: A narrative literature review was conducted using PubMed/MEDLINE, Scopus, Web of Science, and Google Scholar, from database inception to September 2026. The review addressed the links between obesity, inflammation, and MetS, the associations of these markers with cardiometabolic abnormalities, and their potential changes following BS. Results: NLR showed the most consistent associations with MetS, insulin resistance, and cardiometabolic risk. Evidence for PLR was less consistent, while MLR remained comparatively underinvestigated. Higher SII values were associated with obesity, MetS, hypertension, and glycemic abnormalities, whereas SIRI was linked to cardiovascular risk and adverse cardiometabolic profiles. Elevated PIV was also associated with obesity, diabetes, MetS, and insulin resistance. UHR was associated with MetS, insulin resistance, and other cardiometabolic abnormalities, although its discriminatory performance and clinical applicability remain limited. Following BS, changes in hematological inflammatory indices have been reported alongside weight loss and improvements in metabolic and inflammatory profiles; however, evidence regarding postoperative changes in SII, SIRI, and particularly PIV remains limited. Conclusions: Hematological inflammatory indices and biochemical ratios may complement cardiometabolic assessment, but their associations with MetS vary across markers and populations. The lack of validated cutoffs and established incremental predictive value limits their current clinical application. Prospective studies are needed to establish their prognostic value and clinical utility.

doi.org/10.3390/medsci14070788Biomarkers

AgingResearch.News